We briefly touch upon some of the available information for upcoming drugs below, both in the US and abroad: Tern Pharmaceutical (TERN): TERN-601 TERN-601 is a preclinical GLP1R agonist , which in mice has been shown to be able to reduce food intake, slow gastric emptying and improve glucose tolerance
Neurology 203 (2), 512520
, 40- , L-
After lifestyle modification and metformin, treatment intensification depends on individual circumstances: Cardiovascular disease, heart failure or chronic kidney disease : SGLT2 inhibitors are generally preferred first-line options for these patients
Test sessions were conducted on the first, third, and eighth injection days (termed injection 1, injection 3, and injection 8, respectively) and on post-treatment days 1 and 3 (see Figure 3A), and training sessions were withheld except for the test sessions